EDGAR Filing Documents for 0000912057-15-000444

Form DRS/A - Draft Registration Statement: [Amend]

SEC Accession No. 0000912057-15-000444

Filing Date

2015-12-10

Accepted

2015-12-10 17:07:21

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS/A	2005492
2		g32806.jpg	GRAPHIC	48754
3		g40836.jpg	GRAPHIC	20901
4		g120208.jpg	GRAPHIC	34403
5		g510472.jpg	GRAPHIC	29764
6		g523152.jpg	GRAPHIC	46651
7		g525812.jpg	GRAPHIC	65217
8		g567161.jpg	GRAPHIC	68932
9		g618617.jpg	GRAPHIC	81472
10		g673198.jpg	GRAPHIC	51867
11		g683841.jpg	GRAPHIC	38803
12		g815073.jpg	GRAPHIC	26857
13		g894075.jpg	GRAPHIC	49108
	Complete submission text file	0000912057-15-000444.txt		2782973

Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010

Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520

Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)